Indications of aerosolized antibiotics in mechanically ventilated patients;Indications des aérosols d'antibiotiques chez les patients sous ventilation mécanique

Reanimation

Volumn 23, Issue 3, 2014, Pages 271-277

  Clavel, M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Aerosol; Antibiotic; Mechanical ventilation; Tracheobronchitisassociated pneumonia; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

AEROSOL; ANTIBIOTIC THERAPY; DRUG INDICATION; HUMAN; REVIEW; TRACHEOBRONCHITIS; TREATMENT RESPONSE; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84904051397     PISSN: 16240693     EISSN: 19516959     Source Type: Journal    
DOI: 10.1007/s13546-014-0861-5     Document Type: Review

References (60)

1. Bergmans DC, Bonten MJ, Gaillard CA, et al (1997) Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39:527-35 (Pubitemid 27196953)
2. Safdar N, Dezfulian C, Collard HR, et al (2005) Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 33:2184-93
3. Muscedere JG, Martin CM, Heyland DK (2008) The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 23:5-10 (Pubitemid 351400351)
4. Nguile-Makao M, Zahar JR, Français A, et al (2010) Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 36:781-9
5. Trouillet JL, Chastre J, Vuagnat A, et al (1998) Ventilatorassociated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:531-9 (Pubitemid 28090546)
6. Shlaes DM (2003) The abandonment of antibacterials: why and wherefore? Curr Opin Pharmacol 3:470-3
7. Infectious Diseases Society of America (2004) Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. Infectious Diseases Society of America, Alexandria, VA
8. Scheetz MH, Wunderink RG, Postelnick MJ, et al (2006) Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy 26:539-50
9. Cantón R, Cobos N, De Gracia J, et al (2005) Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect 11:690-703 (Pubitemid 41167334)
10. Ramsey BW, Pepe MS, Quan JM, et al (1999) Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 340:23-30 (Pubitemid 29024680)
11. Orriols R, Roig J, Ferrer J, et al (1999) Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 93:476-480 (Pubitemid 29364062)
12. Drobnic ME, Sune P, Montoro JB, et al (2005) Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa . Ann Pharmacother 39:39-44 (Pubitemid 40052376)
13. Collard HR, Saint S, Matthay MA (2003) Prevention of ventilator- associated pneumonia: an evidence-based systematic review. Ann Intern Med 138:494-501
14. Dodek P, Keenan S, Cook D, et al (2004) Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 141:305-13 (Pubitemid 39079293)
15. Crouch TW, Higuchi JH, Coalson JJ, et al (1984) Pathogenesis and prevention of nosocomial pneumonia in a nonhuman primate model of acute respiratory failure. Am Rev Respir Dis 130:502-4 (Pubitemid 14029785)
16. Le Conte P, Potel G, Peltier P, et al (1993) Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis 147:1279-82 (Pubitemid 23149891)
17. Odio W, Van Laer E, Klastersky J. (1975) Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration. J Clin Pharmacol 15:518-24
18. Palmer LB, Smaldone GC, Simon SR, et al (1998) Aerosolized antibiotics reduce sputum volume, purulence in mechanically ventilated patients: delivery and response. Crit Care Med 26:31-7
19. Goldstein I, Wallet F, Robert J, et al (2002) Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 165:171-5 (Pubitemid 34084452)
20. Goldstein I, Wallet F, Nicolas-Robin A, et al (2002) Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 166:1375-81 (Pubitemid 35292705)
21. Luyt CE, Clavel M, Guntupalli K, et al (2009) Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit Care 13:R200
22. Tonnellier M, Ferrari F, Goldstein I, et al (2005) Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia: comparative effects of helium and nitrogen. Anesthesiology 102:995-1000 (Pubitemid 40586541)
23. Rouby JJ, Bouhemad B, Monsel A, et al (2012) Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies. Anesthesiology 117:1364-80
24. Lu Q, Girardi C, Zhang M, et al (2010) Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 36:1147-55
25. Miller DD, Amin MM, Palmer LB et al (2003) Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 168:1205-9 (Pubitemid 37421837)
26. Brain JD, Valberg PA (1979) Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 120:1325-73 (Pubitemid 10207919)
27. Harvey CJ, O'Doherty MJ, Page CJ, et al (1997) Comparison of jet and ultrasonic nebulizer pulmonary aerosol deposition during mechanical ventilation. Eur Respir J 10:905-9 (Pubitemid 27180207)
28. Faurisson F, Dessanges JF, Grimfeld A, et al (1996) Comparative study of the performance and ergonomics of nebulizers in cystic fibrosis. Rev Mal Respir 13:155-62 (Pubitemid 26191543)
29. Dhand R (2002) Nebulizers that use a vibrating mesh or plate with multiple aperture to generate aerosol. Respir Care 47:1406-16
30. O'Riordan TG, Palmer LB, Smaldone GC (1994) Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 149:214-9 (Pubitemid 24066122)
31. Dhand R (2003) Maximizing aerosol delivery during mechanical ventilation: go with the flow and go slow. Intensive Care Med 29:1041-2
32. Fink JB, Dhand R, Grychowski J, et al (1999) Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med 159:63-8 (Pubitemid 29036504)
33. Falagas ME, Siempos II, Bliziotis IA, et al (2006) Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials. Crit Care 10:R123
34. Claridge JA, Edwards NM, Swanson J, et al (2007) Aerosolized ceftazidime prophylaxis against ventilator-associated pneumonia in high-risk trauma patients: results of a double-blind randomized study. Surg Infect (Larchmt) 8:83-90 (Pubitemid 46598298)
35. Wood GC, Boucher BA, Croce MA, et al (2002) Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 22:972-82 (Pubitemid 34831292)
36. Rathgeber J, Zielmann S, Panzer C, et al (1993) Prevention of pneumonia by endotracheal micronebulization of tobramycin. Anasthesiol Intensivmed Notfallmed Schmerzther 28:23-9 (Pubitemid 23115185)
37. Tablan OC, Anderson LJ, Besser R, et al (2004) Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53:1 -36
38. Ahmed QA, Niederman MS (2001) Respiratory infection in the chronically critically ill patient. Ventilator-associated pneumonia and tracheobronchitis. Clin Chest Med 22:71-85 (Pubitemid 32290596)
39. Nseir S, Di Pompeo C, Soubrier S, et al (2004) Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: a case control study. Infection 32:210-6 (Pubitemid 39070600)
40. Nseir S, Di Pompeo C, Soubrier S, et al (2005) Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care 9:R238-R45
41. Palmer L, Smaldone G, Chen J, et al (2008) Aerosolized antibiotics and ventilator associated tracheobronchitis in the intensive care unit. Crit Care Med 36:2008-13
42. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med 171:388-416
43. Michalopoulos A, Kasiakou SK, Mastora Z, et al (2005) Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care Med 9:R53-R9
44. Czosnowski QA, Wood GC, Magnotti LJ, et al (2009) Adjunctive aersolized antibiotics for treatment of ventilator-associated pneumonia. Pharmacotherapy 29:1054-60
45. Kofteridis DP, Alexopoulou C, Valachis A, et al (2010) Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Clin Infect Dis 51:1238-44
46. Hamer DH (2000) Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162:328-30
47. Wood GC, Underwood EL, Croce MA, et al (2010) Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin. Ann Pharmacother 44:1665-8
48. Arnold HM, Sawyer AM, Kollef MH (2012) Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilatorassociated pneumonia. Respir Care 57:1226-33
49. Ioannidou E, Siempos II, Falagas ME (2007) Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 60:1216-26 (Pubitemid 350168316)
50. Hallal A, Cohn SM, Namias N, et al (2007) Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect (Larchmt) 8:73-82
51. Le Conte P, Potel G, Clementi E, et al (2000) Administration of tobramycin aerosols in patients with nosocomial pneumonia: a preliminary study. Presse Med 29:76-8 (Pubitemid 30074538)
52. Rattanaumpawan P, Lorsutthitham J, Ungprasert P, et al (2010) Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother 65:2645-9
53. Klastersky J, Geuning C, Mouawad E, et al (1972) Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest 61:117-20
54. Delissalde F, Amábile-Cuevas CF (2004) Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 24:405-8 (Pubitemid 39369489)
55. Feeley TW, Du Moulin GC, Hedley-Whyte J, et al (1975) Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 293:471-5
56. Michalopoulos A, Kasiakou SK, Falagas ME (2005) The significance of different formulations of aerosolized colistin. Crit Care 9:417-8 (Pubitemid 41136288)
57. Alothman GA, Ho B, Alsaadi MM, et al (2005) Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 127:522-9 (Pubitemid 40229312)
58. Cole PJ (2001) The role of nebulized antibiotics in treating serious respiratory infections. J Chemother 13:354-62
59. Kahler DA, Schowengerdt KO, Fricker FJ, et al (2003) Toxic serum trough concentrations after administration of nebulized tobramycin. Pharmacotherapy 23:543-5 (Pubitemid 36384334)
60. Jaillette E, Nseir S (2011) Relationship between inhaled β-agonists and ventilator-associated pneumonia: a cohort study. Crit Care Med 39:725-30